CFG
MRTX

Citizens Financial Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Citizens Financial Group’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-59
Closed -$7K – 1000
2020
Q2 		$7K Buy
+59
New +$5.72K ﹤0.01% 844

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Citizens Financial Group's MRTX Position: Q3 2020 in Review

Citizens Financial Group sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2020, closing a stake of 59 shares — an estimated $7K sold.

Citizens Financial Group first reported a position in MRTX in Q2 2020 and held it in 1 quarter. The position peaked at $7K in Q2 2020. 225 funds tracked by Wall St. Rank hold MRTX as of Q3 2020.

  • Citizens Financial Group reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Citizens Financial Group sold 59 Mirati Therapeutics, Inc. Common Stock shares in Q3 2020, an estimated $7K.
  • Citizens Financial Group first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Citizens Financial Group's Mirati Therapeutics, Inc. Common Stock position peaked at $7K in Q2 2020.
  • 225 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2020.

Based on Citizens Financial Group's 13F filing for Q3 2020, filed 12 Nov 2020.